CIK 0001636282
- Large accelerated filer
Spyre Therapeutics, Inc.
Sign in to watch- Ticker
- SYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464312787
- Phone
- +1 617-651-5940
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aeglea BioTherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,349,597
- in 6 filings, $12.3M under 10b5-1 plans
Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-07 | Quinn Anthony G. President & CEO | Option exercise · Director Stock Option (right to buy) | −18,584 | 144,950 | ||
| 2018-09-27 | Schuchart Aaron Chief Business Officer | Sale | −100 | $9.55 | $955 | 8,400 |
| 2018-09-27 | Schuchart Aaron Chief Business Officer | Sale | −5,900 | $9.50 | $56K | 2,500 |
| 2018-08-17 | Schuchart Aaron Chief Business Officer | Option exercise | +8,500 | $3.50 | $30K | 8,500 |
| 2018-08-17 | Schuchart Aaron Chief Business Officer | Option exercise · Employee Stock Option (right to buy) | −8,500 | 91,500 | ||
| 2018-08-15 | Quinn Anthony G. President & CEO | Purchase | +994 | $9.13 | $9K | 95,787 |
| 2018-08-13 | GEORGIOU GEORGE Director | Option exercise | +17,333 | $7.28 | $126K | 155,861 |
| 2018-08-13 | GEORGIOU GEORGE Director | Option exercise | +20,000 | $4.73 | $95K | 175,861 |
| 2018-08-13 | GEORGIOU GEORGE Director | Option exercise · Director Stock Option (right to buy) | −17,333 | 6,667 | ||
| 2018-08-13 | GEORGIOU GEORGE Director | Option exercise · Director Stock Option (right to buy) | −20,000 | 10,000 | ||
| 2018-07-18 | Quinn Anthony G. President & CEO | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2018-07-18 | Quinn Anthony G. President & CEO | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-07-18 | Quinn Anthony G. President & CEO | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2018-07-18 | Quinn Anthony G. President & CEO | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2018-07-13 | LAWLIS V BRYAN Director | Grant or award · Director Stock Option (right to buy) | +36,800 | 36,800 | ||
| 2018-07-12 | Quinn Anthony G. Interim CEO | Option exercise | +24,000 | $7.04 | $169K | 77,927 |
| 2018-07-12 | Quinn Anthony G. Interim CEO | Option exercise | +14,866 | $6.31 | $94K | 92,793 |
| 2018-07-12 | Quinn Anthony G. Interim CEO | Option exercise · Director Stock Option (right to buy) | −24,000 | 0 | ||
| 2018-07-12 | Quinn Anthony G. Interim CEO | Option exercise · Director Stock Option (right to buy) | −14,866 | 163,534 | ||
| 2018-07-11 | Quinn Anthony G. Interim CEO | Option exercise | +3,307 | $5.46 | $18K | 53,927 |
Page 16 of 19 · 372 trades